Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Aurobindo gets FDA approval for generic Arixtra
The Food and Drug Administration recently approved Aurobindo’s generic of Mylan’s Arixtra (fondaparinux sodium) injection.
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Roche is set to announce its full-year results and expectations for 2018 on Feb.
US patent office rejects Concert Pharma's petition against Incyte
The US Patent and Trademark Office has rejected a petition filed in July last year by Concert Pharmaceuticals challenging a patent awarded to Incyte Pharmaceuticals.
Eisai completes oral solid dose production facility in China
Japanese pharma major Eisai says its Chinese subsidiary, Eisai China Inc (ECI) has completed construction of a new oral solid dose (OSD) production facility and an administration build...
Drugmaker Dermapharm gears up for likely first German IPO of 2018
FRANKFURT (Reuters) - German drugmaker Dermapharm is preparing for an initial public offering (IPO), probably stealing a march on much larger Siemens’ healthcare unit Healthineers as...
Cdc_ Flu season far from over
It’s not the worst flu season in the past decade, the Centers for Disease Control and Prevention shared during a press conference Friday morning.
Canada issues safety warning for Boehringer's Ofev after fatality
Canada’s medicines regulator has issued a safety warning related to Boehringer Ingelheim’s idiopathic pulmonary fibrosis (IPF) therapy Ofev (nintedanib).
EU approves AZ’ biologic Fasenra for severe asthma
AstraZeneca’s biologic Fasenra has been approved for use in Europe as an add-on maintenance treatment in patients with severe eosinophilic asthma.
FDA approves first treatment for breast cancer with a certain inherited genetic mutation
SILVER SPRING, Md.
The Laundry List of Reasons Behind Teva Pharmaceutical Industries' 48% Tumble in 2017
What happenedShares of Teva Pharmaceutical Industries (NYSE.
Glaxo CEO Replaced 50 Top Managers in Shakeup to Spur Growth
GlaxoSmithKline Plc’s new chief executive officer, Emma Walmsley, has revamped the top ranks of the U.
Hung out to dry? Axovant’s terrible JPM week
SAN FRANCISCO—David Hung is the CEO who sold his company, Medivation, to Pfizer for $14 billion.
465
466
467
468
469
470
471
472
473
